Tag: Lorraine Chiroiu

Government incentive transforming local biotech sector, report finds

More than a decade after its introduction, the research and development tax incentive has been “life-changing” for Australia’s biotech industry and an example of how effective long-term consistent policy can be, according to AusBiotech chief executive Lorraine Chiroiu. A report commissioned by AusBiotech and completed by Deloitte Access Economics...

Gig Guide: Innovation leader Woodthorpe to chair Cicada

Posted on   |  by Justin Hendry
Science and innovation leader Dr Katherine Woodthorpe has been appointed as the new chair of deep tech incubator Cicada Innovations. Dr Woodthorpe replaces outgoing chair Andrew Rothery, who has...

Industry-first ESG guide for small biotechs

Posted on   |  by Nicole Bittar
Helping companies see the benefit of being commonly understood is the essence of ensuring a comparable environmental, social and governance (ESG) practice for biotechs and medtechs.  This provided the...

AusBiotech unveils 10-year blueprint for the biotech sector

Posted on   |  by Brandon How
Life sciences industry representative body AusBiotech has launched a 10-year strategy for the biotechnology sector in an effort to “herald an era of Australian discovery, translationa and innovation”. The...

End of uncertainty as RDTI reforms finally pass

Posted on   |  by Denham Sadler
The federal government’s “enhanced” reforms to the research and development tax incentive passed Parliament just days after being announced, ending two and a half years of uncertainty for those...

BioTech is hardest hit by R&D changes

Posted on   |  by James Riley
The Life Sciences industry in Australia will be hit disproportionately hard by proposed changes to the R&D Tax Incentive, putting smaller companies at risk and threatening the sector’s ability...